Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Melatonin for ICU Delirium Prevention
NCT06076668Unknown
- Sponsor
- Tanta University
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and melatonin in delirium (3 arms), sponsored by Tanta University. Primary endpoint: The incidence of delirium at 14 days. Status: unknown.
02
Drugs
dexmedetomidinemelatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06076668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06076668.